UnknownNot Applicable

Changes of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation

Austria100 participantsStarted 2014-08

Plain-language summary

Collecting blood, graft liver effluent and urine samples from patients undergoing orthotopic liver transplantation.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * End stage liver disease, chronic liver failure, orthotopic liver transplantation Exclusion Criteria: * Combined transplantations (liver plus kidney or lung), age under 18 y, acute liver failure

What they're measuring

Macrophage Migration Inhibitory Factor in human serum, liver graft effluent and urine

Timeframe: 24 months

Trial details

NCT IDNCT02695979

SponsorMedical University of Vienna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-09

View on ClinicalTrials.gov More Evidence of Liver Transplantation trials